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Dawang ZhouThe Hippo pathway is recognized as an important regu-
lator of tissue growth and cell fate [1-3]. Originally
indentified in Drosophila, the Hippo pathway, also known
as the Salvador–Warts–Hippo pathway, contains core ki-
nases cascade, Hippo and Warts(Wts) coupled by the
scaffold protein Salvador (Sav), as well as Mats. The acti-
vation of the Hippo pathway kinases results in phosphor-
ylation and inactivation of the downstream transcriptional
co-activator Yorkie which binds to the sequence-specific
DNA-binding protein Scalloped and enhances the expres-
sion of proliferative and pro-survival genes. In general, the
primary function of the Hippo signaling pathway is to in-
hibit the activation of Yorkie, inasmuch as deletion of Yki
reverses the overgrowth phenotypes resulted from loss of
Hippo, Warts, Salvador or Mats. Components of the
Hippo pathway are highly conserved throughout evolu-
tion. The counterparts for the Hippo pathway in Drosoph-
ila can all be found in mammals, although they are more
diverse and complex [4]. The Hippo orthologs Mst1 and
Mst2 utilize the Salvador ortholog WW45/Sav1 to regu-
late the Warts orthologs Lats1/Lats2. Activated Lats ki-
nases phosphorylate the transcriptional regulators TAZ/
YAP (Yorkie orthologs) which promotes 14-3-3 binding to
YAP, causing YAP nuclear exit, hereby inhibiting its func-
tion. In recent years, increasing numbers of mammalian
studies have expanded the large proteins network of the
Hippo signaling pathway that controls tissues growth dur-
ing development and regeneration, as well as in patho-
logical states such as cancer [5].
The upstream regulator of the Hippo pathway and the
downstream of Mst1/Mst2 have been diversified consider-
ably in mammals compared with the Drosophila Hippo
pathway. Multiple cellular stresses can trigger an adaptive
response by activating the Hippo signaling pathway, which
may, in turn, maintain the cellular homeostasis. The
Hippo/Warts/Mats/Yorkie pathway predicated in Dros-
ophila is not universal in all mammalian tissues in whichCorrespondence: dwzhou@xmu.edu.cn
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reproduction in any medium, provided the ortheir regulation and function are different in selected cell
types. For examples, Mst1/2 negatively regulates YAP1 in
mammalian liver, however, Mst1/2 is not required for
YAP1 phosporylation and nuclear exclusion resulted from
the cell-cell contact in mouse embryonic fibroblasts
(MEFs); Mst1/2 is dispensable for Lats1/2 signaling in
MEFs, but not in HeLa cells [6]. Independent of YAP,
Mst1 negatively regulates naïve T cell proliferation upon
the T cell receptor stimulation, as well as regulates periph-
eral naïve T cell trafficking and thymus egress [7]. Further-
more, patients with Mst1 deficiency are reported to have a
primary immunodeficiency phenotype [8,9]. During the
tissues regeneration and tumorigenesis, the Hippo signal-
ing pathway has been shown to cross talk with other sig-
naling players such as Notch and Wnt [10]. Thus, not just
for the organ size control, the Hippo pathway receives in-
puts from multiple extracellular or intracellular signals
and interacts with other essential signaling pathways to
play critical roles in many aspects for cell fate decisions.
In this issue of the Cell & Bioscience, we have provided
some updates on the regulations beyond the canonical
Hippo signaling, and their implications in pathological
states. Qin et al. will review the recent updates of the roles
of Mst1/2 on the cellular redox state regulation, the effects
of Mst1/2 deficiency on the development process and
tumorigenesis in multiple organs, and their involvement
in the immune regulation. The review by Hergovich will
summarize the current understanding of mammalian
Lats1/2 kinases together with their closest relatives, the
NDR1/2 kinases. He will focus on discussion about the
regulation of the LATS/NDR family of kinases and their
currently known substrates, as well as the biological roles
of LATS/NDR kinases. Guo and Zhao follows with a dis-
cussion of the function of YAP and TAZ as effectors of
cell responses to several extracellular signals including
mechanical stress, GPCR signaling, and the Wnt signaling
pathway, emphasizing that YAP and TAZ might have dif-
ferent role with cell-type specificity in the promotion of
specific cancers. Collectively, these reviews have provided
additional information to address the complexity of theis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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